1. Home
  2. Investments
  3. STIM

The aquaculture industry’s largest quality supplier of fish health products and services

STIM at a glance & key developments in 2025

STIM is the leading supplier of fish health products and services to the aquaculture industry. With over 33 years of experience, STIM offers a holistic approach that combines expertise in vaccines, pharmaceuticals, environmental monitoring, and regulatory advisory. Operating across Norway, Chile, Scotland, Ireland, Iceland, and North America, STIM supports farmers in improving fish health outcomes and long-term operational sustainability.

In recent years, STIM has continued to expand its distribution network and proprietary product portfolio while deepening its advisory offering, including through the acquisition of Pharmaq Analytic’s fish health and environmental services in the UK and Ireland.

Year acquired
2024
Revenue
EUR 170m
Location
Norway
Employees
104
Investment theme
Sustainable Food
SDG alignment

2, 14

What are the challenges Stim addresses

  • USD ~2bn

    in revenue loss for salmon farmers from mortality and downgrades

  • >15%

    fish mortality in salmon farming

  • Who is impacted?

    Fish farmers, coastal communities, marine ecosystems and society at large are impacted by STIM’s fish health products and services. Farmers benefit from improved fish health and operational stability, while healthier farming practices reduce biological stress and environmental pressure on surrounding marine ecosystems.

  • Contribution

    STIM contributes to Summa’s theory of change by improving fish health and welfare through preventative treatments, monitoring and advisory services. By supporting disease management and responsible farming practices, STIM helps farmers run more stable, productive and sustainable operations.

  • Risks to impact

    Key risks to impact include limited control over farming practices and treatment application beyond STIM’s direct oversight, as well as environmental effects in marine environments. These factors may reduce the effectiveness of STIM’s solutions in improving fish health and minimizing environmental impact.

KPI reporting

Distributed amount of preventative treatments and products

Target 2029: 356k

Change from '24-'25: -39%

2025
187k
2024
307k
2023
N/A

Tracks the amount of preventative treatments and products distributed by STIM, including pharmaceuticals and natural fish health products, supporting improved fish health management across the aquaculture industry.

Projects supporting marine environment and fish health

Target 2029: 3.6k

Change from '24-'25: +45%

2025
2.9k
2024
2k
2023
N/A

Tracks the number of advisory projects delivered by STIM across marine environment and fish health. Projects include veterinary visits and environmental monitoring and assessments to support sustainable aquaculture decisions.

Estimated number of fish supported through proprietary health products

Target 2029: 89.4m

Change from '24-'25: +11%

2025
77.9m
2024
70m
2023
N/A

Tracks the estimated number of fish supported through STIM’s proprietary health and biosecurity products, reflecting the scale of the company’s contribution to more sustainable aquaculture practices.